636 studies on GLP-1 agonist class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Oral semaglutide could offer a safer, more effective, and convenient alternative to insulin for managing post-transplant hyperglycemia, potentially mitigating risks like hypoglycemia and weight gain in a highly vulner…
This study is crucial for understanding how Semaglutide performs in a diverse patient population under typical healthcare conditions, rather than idealized trial environments. Real-world evidence complements tradition…
This perspective is crucial for understanding the potential challenges and benefits of using oral semaglutide in patients who have undergone MBS. It suggests that while the drug's mechanism of action is highly relevan…
This review provides crucial, actionable guidance that can significantly enhance patient safety and reduce perioperative complications for a rapidly expanding patient population. By differentiating the management stra…
While specific quantitative results are not detailed in this summary, the study was designed to rigorously evaluate the efficacy of Liraglutide in a challenging patient population. The primary objective was to determi…
The findings from this study are highly significant for patients managing type 2 diabetes and obesity with Tirzepatide. Knowing that injection site (upper arm, thigh, or abdomen) does not significantly impact drug abs…
This research is significant because it addresses a critical health disparity, focusing on Mexican American women who are at elevated risk for type 2 diabetes. Improving beta cell function is a direct strategy to halt…
If the study's findings demonstrate positive effects on cardio-metabolic risk markers, it would reinforce Liraglutide's role as a multi-faceted treatment, offering significant cardiovascular benefits beyond glucose co…
Understanding the link between neuropathy and semaglutide-induced gastric retention is crucial for optimizing patient care and safety. This research could lead to improved risk stratification for diabetic patients con…
The successful completion of a bioequivalence study is a critical step in the drug development process, particularly for generic versions or new formulations of existing medications. Demonstrating bioequivalence means…
This narrative review is crucial because it synthesizes the current understanding of GLP-1 RAs, suggesting they could be a valuable therapeutic strategy for improving the long-term health of cancer survivors. Given th…
If Liraglutide or Metformin were found to positively influence the telomere-telomerase system or Par-4 in Type 2 Diabetes patients, it would provide novel insights into their mechanisms beyond glucose control. This co…
The potential for Liraglutide to address both nicotine dependence and weight management simultaneously is significant, as weight gain is a common barrier to successful smoking cessation. This dual-action approach coul…
This Phase 4 clinical trial provides robust evidence reinforcing that liraglutide, a GLP-1 receptor agonist, is effective in reducing systolic blood pressure in patients with Type 2 diabetes and co-existing hypertensi…
This Phase 1 trial is crucial for understanding the fundamental mechanisms by which liraglutide exerts its metabolic effects in obese individuals, even without specific outcome data in the abstract. By clarifying its …
This Phase 3 study is critical because it directly compares two of the most promising pharmacological approaches for obesity management, potentially establishing a new standard of care. The results will provide invalu…
This study is crucial because it addresses a highly underserved patient group: individuals with severe obesity and multimorbidity who cannot undergo bariatric surgery. The findings could establish a new, effective tre…
The key implication of this research is to understand if Liraglutide, a common Type 2 diabetes medication, offers additional benefits for bone health, which is often compromised in diabetic individuals. If Liraglutide…
This study is significant because it provides valuable real-world data on the long-term effectiveness of Xultophy® in a diverse patient population, complementing controlled clinical trial findings. Understanding how a…
Understanding the specific metabolic changes induced by CagriSema versus diet-induced weight loss is crucial for optimizing obesity treatment strategies. If CagriSema demonstrates superior or distinct metabolic benefi…
This study provides compelling evidence that semaglutide could be a groundbreaking treatment option for individuals struggling with Alcohol Use Disorder, particularly those with comorbid obesity. Given the high global…
The preservation of bone health during weight loss is a critical consideration, especially for postmenopausal women who are already susceptible to bone density loss and fracture risk. This study is significant because…
This study provides compelling evidence that GLP-1 medicines may offer substantial benefits beyond their primary role in weight loss and metabolic health. The observed improvements in mental health, eating disorder sy…
This review represents a conceptual shift in T2D management, proposing that cognitive preservation should become an explicit therapeutic objective, integrated with metabolic control. The identification of existing glu…
This study reveals a notable disparity in the utilization of GLP1RAs among individuals with multiple sclerosis who possess cardiometabolic comorbidities that would warrant such treatment. The findings underscore the i…
The findings from this study, once published, could significantly advance our understanding of GLP-1 agonists beyond weight loss, specifically in treating binge eating disorder. If Liraglutide proves effective, it cou…
Establishing bioequivalence between different drug formulations is crucial for drug development. It ensures that any changes in formulation (e.g., for improved stability, manufacturing, or patient convenience) do not …
This Phase III comparative trial is significant because it directly compares three different GLP-1 RA formulations, potentially providing crucial data to guide treatment selection for obese patients. The findings coul…
PCOS is a complex condition with significant unmet needs, particularly for obese and infertile women who struggle with its multifaceted symptoms. If liraglutide demonstrates superior or even comparable efficacy to met…
If successful, this line of research could reposition GLP-1 agonists as potential neuroprotective agents, expanding their therapeutic utility beyond metabolic disorders. The findings, had they been positive, could hav…